YING WANG: Open Payments
NPI 1336562727 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 31 payments from 8 companies in 2025. Trend: 2023 $22 · 2024 $216 · 2025 $726
Food & beverage: $625Education: $101
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $187 |
| Teva Pharmaceuticals USA, Inc. | 5 | $183 |
| ABBVIE INC. | 5 | $121 |
| Alkermes, Inc. | 4 | $96 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: COBENFY, VRAYLAR, ARISTADA, AUSTEDO XR, INGREZZA, Auvelity, REXULTI, LYBALVI.
Industry payments across GA — which companies pay providers there.
